Skip to content

Closed Incision Negative Wound Pressure Therapy on Wound Healing and Scar Quality After Mastectomies in Transgender Men.

Closed Incision Negative Wound Pressure Therapy on Wound Healing and Scar Quality After Mastectomies in Transgender Men. - PICO-trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48586
Enrollment
85
Registered
2018-06-21
Start date
2018-09-05
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mastectomy transgender

Interventions

Both mastectomy sites will be closed conventionally and in accordance to standard practice. All mastectomies will be randomly assigned one control side and one case side that will receive the additi

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Trans men requiring a mastectomy.

Exclusion criteria

Exclusion criteria: - Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissue diseases, any kind of congenital defect of metabolism including insulin-dependent diabetes mellitus, Cushing syndrome or disease, scurvy, chronic hypothyroidism, congenital or acquired immunosuppressive condition, chronic renal failure, or chronic hepatic dysfunction (Child-Pugh class B or C), severe malnutrition, or other concomitant illness which, in the opinion of the Investigator, has the potential to significantly delay wound healing) - Severe drug, smoking (> 1 pack a day; 22 cigarettes) and alcohol abuse (>10 alcoholic units a week) - Patients expected not to comply with the study protocol (including patients with severe cognitive dysfunction/impairment and severe psychiatric disorders) - Allergy to silver or acrylic adhesives: PICO* has an acrylic adhesive coating and a skin interface layer with silver, which may present a risk of an adverse reaction in patients who are allergic or hypersensitive to acrylic adhesives

Design outcomes

Primary

MeasureTime frame
The primary parameters will concern wound healing complications (infection, seroma, hematoma, dehiscence, reoperation).

Secondary

MeasureTime frame
The secondary parameters will concern the outcomes of scar quality (POSAS, SCAR-Q, Cutometer® and DSM-II colormetric evaluation). Additional endpoints will be revision surgery, CHEST-Q scores, nipple survival.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)